dc.contributor.author | Albayrak, Yakup | |
dc.contributor.author | Hashimoto, Kenji | |
dc.date.accessioned | 2022-05-11T14:41:03Z | |
dc.date.available | 2022-05-11T14:41:03Z | |
dc.date.issued | 2013 | |
dc.identifier.issn | 1738-3684 | |
dc.identifier.issn | 1976-3026 | |
dc.identifier.uri | https://doi.org/10.4306/pi.2013.10.4.417 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/9040 | |
dc.description.abstract | Fluvoxamine is a selective serotonin reuptake inhibitor that is approved for psychiatric disorders such as major depressive episodes and obsessive-compulsive disorder. Beside inhibition of serotonin reuptake, fluvoxamine is also a potent agonist of endoplasmic reticulum (ER) protein sigma-1 receptors, which play a role in the pathophysiology of a number of psychiatric and neurodegenerative disorders. This report presents beneficial effects of sigma-1 agonist fluvoxamine on hyperkinetic movement disorders such as tardive dyskinesia and tardive akathisia. Fluvoxamine might be a novel treatmet approach in the treatment of hyperkinetic movement disorders. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Korean Neuropsychiatric Assoc | en_US |
dc.identifier.doi | 10.4306/pi.2013.10.4.417 | |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Sigma receptor | en_US |
dc.subject | Fluvoxamine | en_US |
dc.subject | Akathisia | en_US |
dc.subject | Dyskinesia | en_US |
dc.subject | Induced Movement-Disorders | en_US |
dc.subject | Neuropsychiatric Disorders | en_US |
dc.subject | Receptor Ligands | en_US |
dc.subject | Tomography | en_US |
dc.subject | Chaperone | en_US |
dc.subject | Dopamine | en_US |
dc.subject | Stress | en_US |
dc.subject | Brain | en_US |
dc.subject | Drugs | en_US |
dc.title | Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia and Tardive Akathisia in Patients with Schizophrenia: Report of Three Cases | en_US |
dc.type | article | en_US |
dc.relation.ispartof | Psychiatry Investigation | en_US |
dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Ruh Sağlığı ve Hastalıkları Ana Bilim Dalı | en_US |
dc.authorid | 0000-0002-8892-0439 | |
dc.identifier.volume | 10 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 417 | en_US |
dc.identifier.endpage | 420 | en_US |
dc.institutionauthor | Albayrak, Yakup | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 29067508300 | |
dc.authorscopusid | 55365316700 | |
dc.authorwosid | Albayrak, Yakup/ABA-7651-2020 | |
dc.authorwosid | Hashimoto, Kenji/I-5800-2015 | |
dc.identifier.wos | WOS:000329599900015 | en_US |
dc.identifier.scopus | 2-s2.0-84892550172 | en_US |
dc.identifier.pmid | 24474992 | en_US |